Pembrolizumab, Tumor Response, and Survival in Advanced Melanoma

Interview with Antoni Ribas, MD, PhD, author of Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma
Source: JAMA Author Interviews - Category: Journals (General) Authors: Source Type: podcasts